Announcements Trials

Browse Landscape

Sponsor

Conditions

Colorectal Neoplasms 50 Carcinoma, Non-Small-Cell Lung 26 Squamous Cell Carcinoma of Head and Neck 25 Head and Neck Neoplasms 12 Neoplasm Metastasis 11 Neoplasms 10 Colonic Neoplasms 10 Rectal Neoplasms 9 Pancreatic Neoplasms 9 Lung Neoplasms 9 Mouth Neoplasms 6 Carcinoma, Squamous Cell 6 Carcinoma 6 Laryngeal Neoplasms 5 Hypopharyngeal Neoplasms 5 Oropharyngeal Neoplasms 4 Thyroid Neoplasms 3 Solid Tumors 3 Ovarian Neoplasms 3 Gastrointestinal Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Pancreatic Ductal 3 Breast Neoplasms 3 Sarcoma 2 Recurrence 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Laryngeal Diseases 2 mCRC 1 Urologic Neoplasms 1 Triple Negative Breast Neoplasms 1

Interventions

fludarabine 1 aldesleukin 1 Cyclophosphamide 1 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Adenosquamous × Cetuximab × 90 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡